Hydrix Group’s innovation engine delivers world class design, engineering and regulatory services
Diagnostic, monitoring & interventional MedTech products which improve patient quality of life
Pick winning investments in high potential client medical technologies
29 April 2021 Quarterly Activities Report and Appendix 4C
31 MARCH 2021 Hydrix Medical - Business Update
23 MARCH 2021 Appendix 2A
26 FEBRUARY 2021 Half Year Trading Update
26 FEBRUARY 2021 Appendix 4D and Half-Yearly Report
29 JANUARY 2021 Quarterly Activities Report and Appendix 4C
11 DECEMBER 2020 Results Announcement - Final
11 DECEMBER 2020 Executive Chairman's Address - Lodgement Final
10 DECEMBER 2020 Hydrix announces first in human trials of Phyzhon Health's PHYRARI FFR-WIRE
12 NOVEMBER 2020 Notice of Annual General Meeting an explanatory memorandum
12 NOVEMBER 2020 Letter to Shareholders - Annual General Meeting
30 OCTOBER 2020 HYD ASX Announcement Phyzhon 30 October 2020
30 OCTOBER 2020 Hydrix - Capital Raising Presentation 30 October 2020
30 OCTOBER 2020 Appendix 3B (online form)_placement (SH approval)
To view past announcements visit the Hydrix page on the ASX
Please click the image above to access our Annual Report
Please click the image above to access our Shareholder Newsletter
For all shareholder enquiries, please contact us via the form below:
To view the latest Hydrix share price and announcements, visit the Hydrix page on the ASX
Hydrix Executive Chairman, Gavin Coote, hosted an investor conference call to discuss financial results
The Market Unpacked interviews Gavin Coote, Hydrix Executive Chairman
Journalist Tim Boreham discovers a quiet achiever propelling the MedTech industry
Hydrix tries to cut through complexity with promises of $$$